P res. Donald Trump says Americans could soon pay far less for GLP-1 medications used for diabetes, obesity, and heart ...

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

Scientists have known that obesity and metabolic dysfunction can make cancers more aggressive. Tumors thrive in bodies ...

America’s adult obesity rate has finally begun to dip after years of stagnation — down to 37% in 2025 from nearly 40% in 2022 ...

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

As students prepare for course selection at Colgate University, the abundance of available classes becomes very apparent.

Injectable weight-loss drugs such as Ozempic and Mounjaro may do more than help people shed pounds—they may also protect the ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to tinostamustine, an investigational therapeutic from Purdue Pharma L.P., for the treatment of patients with malignant ...

Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...

A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug ...